ELISA,항체,단백질
[Product Guide] Monoclonal Antibodies_Biosynth Carbosynth - 코아사이언스
코피디
2022. 3. 28. 10:11
Monoclonal Antibodies
Introduction
Monoclonal antibodies (mAbs) typically bind to a single antigenic epitope (monovalent affinity). They can be produced using hybridomas or through recombinant production techniques. Biosynth Carbosynth offer a range of monoclonal antibodies for research against targets involved in cancer, multiple sclerosis, and other diseases.
| Cat.# | Cas No | Product | Description |
| BA165581 | 216503-57-0 | Alemtuzumab | Monoclonal antibody against CD52; treatment for multiple sclerosis; anti-cancer |
| BA165582 | 1245916-14-6 | Alirocumab - solution - 75 mg/ml | Monoclonal antibody to PCSK9 ; inhibitor of proprotein convertase PCSK9 |
| BA165584 | 1380723-44-3 | Atezolizumab | Monoclonal antibody against PDL-1; anti-cancer agent |
| BB164045 | 2088770-90-3 | Brentuximab | Antibody-drug conjugate targeting CD30; antineoplastic |
| BD164046 | 1363687-32-4 | Dinutuximab | Anti-GD2 monoclonal antibody |
| BD165585 | 615258-40-7 | Denosumab | Monoclonal antibody against RANKL; anti-resorptive agent for osteoperosis treatment |
| BD165586 | 945721-28-8 | Daratumumab - 20mg/ml in water | Monoclonal antibody against CD38; treatment for multiple myeloma |
| BE165588 | 219685-50-4 | Eculizumab | Monoclonal antibody against complement protein C5 |
| BE165589 | 1256937-27-5 | Evolocumab - solution - 5 mg/ml | Inhibts PCSK9; hypercholesterolemia therapy |
| BI164048 | 477202-00-9 | Ipilimumab | Monoclonal antibody against CTLA-4 |
| BM165590 | 339186-68-4 | Matuzumab - 10mg/ml | Intereferes with EGFR homodimerisation; cancer therapy |
| BM168494 | 196078-29-2 | Mepolizumab | Monoclonal antibody for treatment of eosinophilic asthma |
| BN164047 | 946414-94-4 | Nivolumab - >10mg/ml | Monoclonal antibody against PD-1 checkpoint protein |
| BN165591 | 780758-10-3 | Nimotuzumab | Intereferes with EGFR ligand binding; cancer therapy |
| BO164044 | 679818-59-8 | Ofatumumab | Monoclonal antibody against CD20 |
| BO165592 | 949142-50-1 | Obinutuzumab - Buffer solution | Activates B-cell apoptosis; treatment of B-cell malignancies |
| BP164049 | 1374853-91-4 | Pembrolizumab - in storage buffer | Monoclonal antibody against PDL1; cancer immunotherapy |
| BP165593 | 380610-27-5 | Pertuzumab | Blocks HER-2 heterodimerization; breast cancer therapy |
| BR167936 | 174722-31-7 | Rituximab - 10mg/ml solution | Chimeric monoclonal antibody against CD20 Therapeutic monoclonal antibody in multiple sclerosis |
| FR138503 | 174722-31-7 | Rituximab - 20mg/ml solution | Chimeric monoclonal antibody against CD20 Therapeutic monoclonal antibody in multiple sclerosis |
| BR171775 | 347396-82-1 | Ranibizumab - 10mM histidine- histidine HCl buffer | Monoclonal antibody against VEGF-A |
| FR139132 | 347396-82-1 | Ranibizumab - 25mg/ml solution in PBS | Monoclonal antibody against VEGF-A |
| BS165594 | 875356-43-7 | Secukinumab | Inactivates IL-17A; psoriasis therapy |
| BU165596 | 815610-63-0 | Ustekinumab | Inhibits pro-inflammatory cytokines IL-12 and IL-23; psoriasis therapy |
| BV165597 | 943609-66-3 | Vedolizumab | Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapy |
| FC64978 | 205923-56-4 | Cetuximab - Buffer solution | Monoclonal antibody against EGFR; treatment for colorectal cancer |
| FB168813 | 1407495-02-6 | Bococizumab | Monoclonal antibody against PCSK9 |
| BT165595 | 375823-41-9 | Tocilizumab - 20mg/ml in PBS | Interleukin-6 competitor blocks IL-6 receptor; immunosuppressive agent. |
| FR159043 | 947687-13-0 | Ramucirumab | Monoclonal antibody to VEGFR-2 |
| FO139134 | 242138-07-4 | Omalizumab - buffer solution | Monoclonal antibody against immunoglobulin E (IgE) |
| FP139135 | 188039-54-5 | Palivizumab | Monoclonal antibody against the F protein of RSV |
| FP30153 | 339177-26-3 | Panitumumab - buffer solution | Monoclonal antibody against EGFR |
| FI139130 | 170277-31-3 | Infliximab | Chimeric monoclonal antibody against TNFα |
| FI139131 | 331731-18-1 | Adalimumab | Monoclonal antibody against TNFα; therapy for rheumatoid arthritis |
| FT65040 | 180288-69-1 | Trastuzumab - 20mg/ml in PBS | Monoclonal antibody against HER2 for breast cancer treatment |
| FN139133 | 189261-10-7 | Natalizumab | Monoclonal antibody against α4-integrin |
| FB76708 | 216974-75-3 | Bevacizumab - 25mg/ml solution in PBS | Monoclonal antibody against VEGF |
| BC176794 | 914613-48-2 | Canakinumab | Monoclonal antibody against human interleukin-1β |
| FC181537 | 2415933-42-3 | Casirivimab | Monoclonal antibody against spike protein RBD of SARSCoV-2 |
| FI181538 | 2415933-40-1 | Imdevimab | Monoclonal antibody against spike protein RBD of SARSCoV-2 |
| DHC93560 | 1428935-60-7 | Durvalumab | Monoclonal antibody against PD-L1 |
| BA165583 | 1537032-82-8 | Avelumab - in PBS buffer | Monoclonal antibody against PDL-1; targeted immunotherapy for cancer |
* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.
코아사이언스 coresciences Biosynth Carbosynth limited UK Korea 한국 대리점 distributor